Prelude-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
1,078
Total Value
963467316
Accession Number
0000945621-25-000489
Form Type
13F-HR
Manager Name
Prelude-Capital-Management
Data Enrichment
90% identified
969 identified109 unidentified

Holdings

1,078 positions
Manager:
Search and click to pin securities to the top
Page 54 of 54
Inhibikase Therapeutics, Inc.
Shares:11.1K
Value:$24.3K
KOPIN CORP
Shares:25.8K
Value:$24.1K
SANGAMO THERAPEUTICS, INC
Shares:34.4K
Value:$22.5K
45826T509
Shares:17.4K
Value:$21.5K
Vuzix Corp
Shares:10.5K
Value:$21.5K
Bitfarms Ltd
Shares:24.2K
Value:$19.0K
Whitehawk Therapeutics, Inc.
Shares:10.2K
Value:$18.2K
Aclaris Therapeutics, Inc.
Shares:11.8K
Value:$18.0K
Caribou Biosciences, Inc.
Shares:19.2K
Value:$17.5K
Tilray Brands, Inc.
Shares:23.9K
Value:$15.7K
AMERICAN BATTERY TECHNOLOGY Co
Shares:14.3K
Value:$14.7K
Origin Materials, Inc.
Shares:20.2K
Value:$13.4K
Ondas Holdings Inc.
Shares:11.0K
Value:$11.8K
BIODESIX INC
Shares:11.7K
Value:$7.3K
Athira Pharma, Inc.
Shares:11.0K
Value:$3.1K
731105102
Shares:16.5K
Value:$3.0K
86889P117
Shares:24.6K
Value:$738
485859110
Shares:28.7K
Value:$255